FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes

The FDA authorized Philip Morris to market Zyn nicotine pouches with a "reduced exposure" claim, meaning the products expose users to lower levels of harmful chemicals than cigarettes. Philip Morris submitted a modified risk tobacco product application, which the FDA reviewed and approved. The authorization allows the company to market the pouches as presenting lower health risks than conventional cigarettes. Public health organizations have raised concerns about the marketing of nicotine products to youth.

Next story